Today: 17 January 2026
Subscribe
Browse Category

Health Insurance News 17 October 2025 - 28 November 2025

UnitedHealth Group (UNH) Stock: What to Watch Before the November 28, 2025 Open

UnitedHealth Group (UNH) Stock: What to Watch Before the November 28, 2025 Open

UnitedHealth Group Incorporated (NYSE: UNH) heads into Friday’s shortened Black Friday session still carrying one of the ugliest year‑to‑date charts in the Dow – and some of the heaviest policy and legal baggage in the U.S. healthcare sector. After a brutal sell‑off driven by soaring medical costs, a massive cyberattack and a federal investigation into Medicare billing, UnitedHealth stock has…
28 November 2025
···
Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health, Inc. (NYSE: OSCR) is surging again today. As of mid‑afternoon trading on Wednesday, November 26, 2025, Oscar Health stock is trading around $18.20, up roughly 8–9% on the day, after moving between about $16.20 and $18.60 in today’s session. Timothy Sykes The move extends an already powerful run: shares are up roughly 25% over the past week, driven…
26 November 2025
··
UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group Incorporated (NYSE: UNH) shares are edging higher today as investors digest fresh policy headlines out of Washington and a wave of new analysis explaining how the stock managed to lose roughly half its value over the past year. By early afternoon, UNH is trading around $322 per share, up about 0.6% on the day, with an intraday range…
24 November 2025
···
Medicare 2026 Premiums Jump Nearly 10%: How Much of Your 2.8% Social Security COLA Will You Actually Keep?

Medicare 2026 Premiums Jump Nearly 10%: How Much of Your 2.8% Social Security COLA Will You Actually Keep?

As of today, November 24, 2025, the picture for retirees in 2026 is getting clearer — and more expensive. The Centers for Medicare & Medicaid Services (CMS) has confirmed that standard Medicare Part B premiums will rise nearly 10% next year, from $185.00 in 2025 to $202.90 in 2026, while the annual deductible will climb from $257 to $283. CMS…
24 November 2025
···
Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025

Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025

Market snapshot As of 14:48 UTC on Nov. 10, CNC traded at $33.91 (intraday range $33.64–$36.09). Why CNC is under pressure today In posts over the weekend, President Donald Trump called for redirecting “hundreds of billions” in ACA subsidy funds directly to consumers, rather than to insurers. By early Monday, managed-care stocks with ACA exposure, including Centene, were lower in…
10 November 2025
Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health, Inc. (NYSE: OSCR) announced new individual-market plans for South Florida ahead of the 2026 Open Enrollment window and spotlighted HelloMeno, a menopause-focused offering it and partner Elektra Health describe as the first plan of its kind in the individual market. The rollout lands as Washington headlines around ACA premium tax credits pressure managed-care shares broadly; investors are watching…
10 November 2025
···
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

What happened in Q3 Oscar Health reported third‑quarter revenue of $2,985,984,000 (in thousands), up from $2,423,482,000 a year ago—about 23% YoY growth, driven largely by higher membership. The medical loss ratio (MLR) increased to 88.5% (from 84.6%), which the company tied to a $130M net risk‑adjustment transfer accrual reflecting higher average market morbidity; this was partly offset by $84M of…
6 November 2025
···
Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

In summary, Humana Inc. faces a pivotal moment: it’s balancing short-term earnings headwinds from elevated costs and rating setbacks against strong long-term fundamentals in the Medicare Advantage space. The latest news (Q3 beat and improved membership outlook) provides some relief that management’s corrective actions are working Reuters Reuters. However, caution prevails as 2026 looms without guidance and with likely flat…
5 November 2025
····
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) Premarket: Analysts Bullish on Comeback Despite 2025 Woes – What to Watch Nov. 3, 2025

UnitedHealth’s volatile 2025 has made UNH a headline story heading into Nov. 3 trading. After a surprise earnings miss in Q1 and a CEO shakeup this spring, UNH plunged to four-year lows. In late Oct. the turnaround narrative got a boost: Q3 beat estimates and management raised guidance Gurufocus Gurufocus. CEO Stephen Hemsley (back at the helm) told investors he’s confident…
2 November 2025
····
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

CI Stock Price and Recent Trend Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the previous close Stockanalysis. The dip followed weakness in broader managed-care stocks amid concerns about healthcare costs and policy. In pre-market…
30 October 2025
····
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Earnings Beat Drives Stock Higher Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predicted Investing. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-year Investing. This robust growth was fueled by higher premium…
21 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: – Oscar Health (NYSE: OSCR) shares have surged in early October 2025, recently trading around $21–22 (up ~40% YTD) ts2.tech Marketbeat. The stock hit about $21.50 on Oct 3 (+11% on the day) and was trading near $21.76 on Oct 14 (+6.7%) ts2.tech Marketbeat. – Oscar announced a $410 million convertible debt offering in September 2025 to fund…
17 October 2025
···
1 2 3 4 5

Stock Market Today

  • Cotton futures fall on Friday as export pace trails five-year average
    January 17, 2026, 5:18 PM EST. Cotton futures fell Friday, with most contracts down 15 to 30 points. The US dollar index was down about 343 points, while crude oil slid $1.64 a barrel. USDA Export Sales for 2024/25 stood at 4.213 million running bales sold or shipped, about 37% of the USDA projection and roughly 12 percentage points behind the five-year average pace. ICE cotton stocks were unchanged at 15,526 bales. The Cotlook A Index dropped 100 points to 78.45 cents per pound. The USDA Average World Price (AWP) for next week rose to 55.35 cents/lb, up 11 points. Quotes: Dec 24 at 67 (-15); Mar 25 at 68.49 (-23); May 25 at 69.76 (-28). On the date of publication, Alan Brugler had no positions.
Go toTop